The pharmaceutical world is seeing a major shift in diabetes therapy with the emergence of GLP-1 transdermal devices. These devices offer a seemingly more comfortable alternative to subcutaneous administrations of GLP-1 medications, minimizing the need for daily needle pokes. The innovation releases the drug directly through the skin, potentiall… Read More